INO-1001 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
INO-1001 is a novel PARP inhibitor, known to sensitize cells to radiation in vitro by inhibiting the repair of DNA damage.
More Information Supplier PageINO-1001 is a novel PARP inhibitor, known to sensitize cells to radiation in vitro by inhibiting the repair of DNA damage.
More Information Supplier PageINO-1001 is a novel PARP inhibitor, known to sensitize cells to radiation in vitro by inhibiting the repair of DNA damage.
More Information Supplier PageIndirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageImatinib mesylate, a selective tyrosine kinase inhibitor, induced a sustained objective response in treating gastrointestinal stromal tumors with the inhibition of the KIT signal-transduction pathway.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier PageIloperidone is an atypical antipsychotic for the treatment of schizophrenia.
More Information Supplier Page